Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 21.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,978 shares of the biotechnology company’s stock after purchasing an additional 1,255 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Axon Enterprise were worth $1,803,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BKM Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $32,000. Key Financial Inc increased its holdings in shares of Axon Enterprise by 367.6% in the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after acquiring an additional 125 shares during the period. Lindbrook Capital LLC increased its holdings in shares of Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock valued at $44,000 after acquiring an additional 52 shares during the period. Rakuten Securities Inc. acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $48,000. Finally, Provence Wealth Management Group acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $80,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. JMP Securities lifted their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 6th. Barclays lifted their price objective on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a research report on Thursday, February 29th. Argus began coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective on the stock. Finally, The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $312.64.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $302.41 on Thursday. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. The firm’s 50-day simple moving average is $302.15 and its 200 day simple moving average is $260.29. The firm has a market capitalization of $22.82 billion, a PE ratio of 131.48 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The business had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. On average, equities research analysts predict that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.